OmnEcoil Instruments

Curated by Signal

Developing the device for tissue sampling and prostate cancer detection

Overview

The OmnEcoil is developing the device for tissue sampling and prostate cancer detection. It's endorectal coil embedded in the device that allows better needle placement for the biopsy sampling without prostrate deformation.

Key facts

Founded: 2016
Headquarters: Portland, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Autentik AI
AI based tools and community engagement to support autistic individuals
Health TechnologyWilmington, United States
American Health Care Software
Software for long- term care, retirement homes, assisted living
Health TechnologySouth Burlington, United States
Hepius
Provider of contact tracing app for workplace safety
Health TechnologySalt Lake City, United States

About OmnEcoil Instruments

What does OmnEcoil Instruments do?

The OmnEcoil is developing the device for tissue sampling and prostate cancer detection.

Where is OmnEcoil Instruments headquartered?

OmnEcoil Instruments is headquartered in Portland, United States.

When was OmnEcoil Instruments founded?

OmnEcoil Instruments was founded in 2016.

Which sector is OmnEcoil Instruments in?

OmnEcoil Instruments operates in Health Technology.

Who are OmnEcoil Instruments's competitors?

Companies similar to OmnEcoil Instruments include Autentik AI, American Health Care Software, and Hepius.